{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T10:53:12Z","timestamp":1792666392526,"version":"4.5.0"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,7,31]],"date-time":"2020-07-31T00:00:00Z","timestamp":1596153600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100011893","name":"Pan American Health Organization","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011893","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1016\/j.vaccine.2020.07.048","type":"journal-article","created":{"date-parts":[[2020,9,21]],"date-time":"2020-09-21T16:55:49Z","timestamp":1600707349000},"page":"B12-B26","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"S2","title":["Adverse events associated with the use of recommended vaccines during pregnancy: An overview of systematic reviews"],"prefix":"10.1016","volume":"39","author":[{"given":"Diego","family":"Macias Saint-Gerons","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iv\u00e1n","family":"Sol\u00e0 Arnau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bremen","family":"De Mucio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingrid","family":"Ar\u00e9valo-Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alicia","family":"Alem\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Luis","family":"Castro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alba Mar\u00eda","family":"Ropero \u00c1lvarez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2020.07.048_b0005","unstructured":"Lacriktz E, Stergachis A, Stepanchack M. Maternal immunization safety monitoring in low- and middle-income countries: a roadmap for program development. Building an approach that is practical, affordable, and sustainable Bill and Melinda Gates Foundation & Global Alliance to Prevent Prematurity and Stillbirth; 2017. Available from: http:\/\/apps.who.int\/medicinedocs\/en\/m\/abstract\/Js23275en\/."},{"issue":"47","key":"10.1016\/j.vaccine.2020.07.048_b0010","doi-asserted-by":"crossref","first-page":"6376","DOI":"10.1016\/j.vaccine.2015.08.036","article-title":"A global perspective of maternal influenza immunization","volume":"33","author":"Lambach","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.07.048_b0015","doi-asserted-by":"crossref","unstructured":"Ingrasciotta Y, Cutroneo PM, Marciano I, Giezen T, Atzeni F, Trifiro G. Safety of biologics, including biosimilars: perspectives on current status and future direction. Drug safety; 2018.","DOI":"10.1007\/s40264-018-0684-9"},{"key":"10.1016\/j.vaccine.2020.07.048_b0020","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s12916-016-0553-2","article-title":"Post-marketing withdrawal of 462 medicinal products because of adverse drug reactions: a systematic review of the world literature","volume":"14","author":"Onakpoya","year":"2016","journal-title":"BMC Med"},{"key":"10.1016\/j.vaccine.2020.07.048_b0025","unstructured":"Global Advisory Committee on Vaccine Safety. Safety of Immunization during Pregnancy A review of the evidence: World Health Organization; 2014. Available from: http:\/\/www.who.int\/vaccine_safety\/publications\/safety_pregnancy_nov2014.pdf."},{"key":"10.1016\/j.vaccine.2020.07.048_b0030","unstructured":"Pan American Health Organization. The Maternal and Neonatal Immunization Field Guide for Latin America and the Caribbean recommends the administration of Influenza (inactivated) and Tetanus\/diphtheria vaccines. Washington, D.C.; 2017. Available from: http:\/\/iris.paho.org\/xmlui\/bitstream\/handle\/123456789\/34150\/9789275119501-eng.pdf."},{"issue":"12","key":"10.1016\/j.vaccine.2020.07.048_b0035","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1007\/s40264-017-0593-3","article-title":"Safety concerns with HPV vaccines continue to linger: are current vaccine pharmacovigilance practices sufficient?","volume":"40","author":"Chandler","year":"2017","journal-title":"Drug Saf"},{"issue":"6","key":"10.1016\/j.vaccine.2020.07.048_b0040","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1002\/pds.3967","article-title":"Fifty years of pharmacovigilance - medicines safety and public health","volume":"25","author":"Laporte","year":"2016","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"1","key":"10.1016\/j.vaccine.2020.07.048_b0045","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1471-2288-11-15","article-title":"Methodology in conducting a systematic review of systematic reviews of healthcare interventions","volume":"11","author":"Smith","year":"2011","journal-title":"BMC Med Res Method"},{"key":"10.1016\/j.vaccine.2020.07.048_b0050","unstructured":"Higgins J, Green S, editors. Cochrane handbook for systematic reviews of interventions. Version 5.1.0 ed: The Cochrane Collaboration; 2011."},{"key":"10.1016\/j.vaccine.2020.07.048_b0055","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.b2535","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"339","author":"Moher","year":"2009","journal-title":"BMJ (Clin Res Ed)"},{"key":"10.1016\/j.vaccine.2020.07.048_b0060","doi-asserted-by":"crossref","unstructured":"Garner P, Hopewell S, Chandler J, MacLehose H, Sch\u00fcnemann HJ, Akl EA, et al. Panel for updating guidance for systematic reviews (PUGs). When and how to update systematic reviews: consensus and checklist. BMJ. 2016;354:i3507.","DOI":"10.1136\/bmj.i3507"},{"key":"10.1016\/j.vaccine.2020.07.048_b0065","article-title":"AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both","volume":"358","author":"Shea","year":"2017","journal-title":"BMJ (Clinical Res Ed)"},{"issue":"4","key":"10.1016\/j.vaccine.2020.07.048_b0070","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.jclinepi.2013.11.007","article-title":"Systematic review finds overlapping reviews were not mentioned in every other overview","volume":"67","author":"Pieper","year":"2014","journal-title":"J Clin Epidemiol"},{"issue":"1","key":"10.1016\/j.vaccine.2020.07.048_b0075","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2165\/11595670-000000000-00000","article-title":"Safety of hepatitis B, pneumococcal polysaccharide and meningococcal polysaccharide vaccines in pregnancy: a systematic review","volume":"35","author":"Makris","year":"2012","journal-title":"Drug Saf"},{"issue":"2","key":"10.1016\/j.vaccine.2020.07.048_b0080","doi-asserted-by":"crossref","first-page":"359","DOI":"10.4269\/ajtmh.2012.11-0525","article-title":"The safety of yellow fever vaccine 17D or 17DD in children, pregnant women, HIV+ individuals, and older persons: systematic review","volume":"86","author":"Thomas","year":"2012","journal-title":"Am J Trop Med Hygiene"},{"key":"10.1016\/j.vaccine.2020.07.048_b0085","article-title":"Influenza vaccination in pregnant women: a systematic review","volume":"2013","author":"Galvao","year":"2013","journal-title":"ISRN Prevent Med"},{"issue":"1","key":"10.1016\/j.vaccine.2020.07.048_b0090","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.healthpol.2013.12.007","article-title":"Effectiveness and cost-effectiveness of different immunization strategies against whooping cough to reduce child morbidity and mortality","volume":"115","author":"Rivero-Santana","year":"2014","journal-title":"Health Policy (Amsterdam, Netherlands)"},{"issue":"5","key":"10.1016\/j.vaccine.2020.07.048_b0095","doi-asserted-by":"crossref","first-page":"e11","DOI":"10.1093\/cid\/ciu915","article-title":"Maternal influenza immunization and birth outcomes of stillbirth and spontaneous abortion: a systematic review and meta-analysis","volume":"60","author":"Bratton","year":"2015","journal-title":"Clin Infect Dis: Off Publ Infect Dis Soc Am"},{"issue":"1","key":"10.1016\/j.vaccine.2020.07.048_b0100","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/1471-0528.12977","article-title":"Fetal death and preterm birth associated with maternal influenza vaccination: systematic review","volume":"122","author":"Fell","year":"2015","journal-title":"BJOG: Int J Obstet Gynaecol"},{"issue":"18","key":"10.1016\/j.vaccine.2020.07.048_b0105","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1016\/j.vaccine.2015.02.068","article-title":"Influenza vaccination during pregnancy: a systematic review of fetal death, spontaneous abortion, and congenital malformation safety outcomes","volume":"33","author":"McMillan","year":"2015","journal-title":"Vaccine"},{"issue":"8","key":"10.1016\/j.vaccine.2020.07.048_b0110","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1111\/aogs.12680","article-title":"Influenza virus infection in pregnancy: a review","volume":"94","author":"Meijer","year":"2015","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"5","key":"10.1016\/j.vaccine.2020.07.048_b0115","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1097\/AOG.0000000000001068","article-title":"Maternal influenza vaccination and risk for congenital malformations: a systematic review and meta-analysis","volume":"126","author":"Polyzos","year":"2015","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.vaccine.2020.07.048_b0120","doi-asserted-by":"crossref","unstructured":"Salam RA, Das JK, Dojo Soeandy C, Lassi ZS, Bhutta ZA. Impact of Haemophilus influenzae type B (Hib) and viral influenza vaccinations in pregnancy for improving maternal, neonatal and infant health outcomes. Cochrane Database System Rev 2015(6):Cd009982.","DOI":"10.1002\/14651858.CD009982.pub2"},{"issue":"11","key":"10.1016\/j.vaccine.2020.07.048_b0125","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1055\/s-0036-1586101","article-title":"The effects of influenza vaccination during pregnancy on birth outcomes: a systematic review and meta-analysis","volume":"33","author":"Nunes","year":"2016","journal-title":"Am J Perinatol"},{"issue":"1","key":"10.1016\/j.vaccine.2020.07.048_b0130","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1186\/s12884-017-1559-2","article-title":"Efficacy and safety of pertussis vaccination for pregnant women \u2013 a systematic review of randomised controlled trials and observational studies","volume":"17","author":"Furuta","year":"2017","journal-title":"BMC Pregnancy Childbirth"},{"issue":"5","key":"10.1016\/j.vaccine.2020.07.048_b0135","doi-asserted-by":"crossref","first-page":"F456","DOI":"10.1136\/archdischild-2016-312341","article-title":"Maternal vaccination against pertussis: a systematic review of the recent literature","volume":"102","author":"Gkentzi","year":"2017","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"issue":"3","key":"10.1016\/j.vaccine.2020.07.048_b0140","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1097\/AOG.0000000000001888","article-title":"Safety of tetanus, diphtheria, and pertussis vaccination during pregnancy: a systematic review","volume":"129","author":"McMillan","year":"2017","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.vaccine.2020.07.048_b0145","article-title":"A systematic review and meta-analysis of fetal outcomes following the administration of influenza A\/H1N1 vaccination during pregnancy","author":"Zhang","year":"2017","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.vaccine.2020.07.048_b0150","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD001269.pub6","article-title":"Di Pietrantonj C. Vaccines for preventing influenza in healthy adults","author":"Demicheli","year":"2018","journal-title":"Cochrane Database System Rev"},{"issue":"3","key":"10.1016\/j.vaccine.2020.07.048_b0155","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1080\/21645515.2018.1540807","article-title":"The safety of inactivated influenza vaccines in pregnancy for birth outcomes: a systematic review","volume":"15","author":"Giles","year":"2019","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2020.07.048_b0160","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/s12978-016-0193-1","article-title":"Global, regional and national levels and trends of preterm birth rates for 1990 to 2014: protocol for development of World Health Organization estimates","volume":"13","author":"Vogel","year":"2016","journal-title":"Reprod Health"},{"issue":"12","key":"10.1016\/j.vaccine.2020.07.048_b0165","article-title":"Acute histologic chorioamnionitis is a risk factor for adverse neonatal outcome in late preterm birth after preterm premature rupture of membranes","volume":"8","author":"Lee","year":"2013","journal-title":"PLoS ONE"},{"issue":"27","key":"10.1016\/j.vaccine.2020.07.048_b0170","doi-asserted-by":"crossref","first-page":"3110","DOI":"10.1016\/j.vaccine.2015.04.097","article-title":"Chorioamnionitis following vaccination in the vaccine adverse event reporting system","volume":"33","author":"Datwani","year":"2015","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.vaccine.2020.07.048_b0175","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1097\/AOG.0000000000000862","article-title":"Pregnancy outcomes after antepartum tetanus, diphtheria, and acellular pertussis vaccination","volume":"125","author":"Morgan","year":"2015","journal-title":"Obstet Gynecol"},{"issue":"34","key":"10.1016\/j.vaccine.2020.07.048_b0180","doi-asserted-by":"crossref","first-page":"5173","DOI":"10.1016\/j.vaccine.2018.07.011","article-title":"Pertussis Immunisation in Pregnancy Safety (PIPS) Study: a retrospective cohort study of safety outcomes in pregnant women vaccinated with the Tdap vaccine","volume":"36","author":"Griffin","year":"2018","journal-title":"Vaccine"},{"issue":"29","key":"10.1016\/j.vaccine.2020.07.048_b0185","doi-asserted-by":"crossref","first-page":"3655","DOI":"10.1016\/j.vaccine.2017.05.041","article-title":"Maternal Tdap vaccination and risk of infant morbidity","volume":"35","author":"DeSilva","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.07.048_b0190","doi-asserted-by":"crossref","unstructured":"GBD 2015 Child Mortality Collaborators. Global, regional, national, and selected subnational levels of stillbirths, neonatal, infant, and under-5 mortality, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet 2016;388(10053):1725\u201374. doi: 10.1016\/S0140-6736(16)31575-6.","DOI":"10.1016\/S0140-6736(16)31575-6"},{"issue":"45","key":"10.1016\/j.vaccine.2020.07.048_b0195","doi-asserted-by":"crossref","first-page":"6736","DOI":"10.1016\/j.vaccine.2018.09.033","article-title":"Vaccine safety surveillance in pregnancy in low- and middle-income countries using GAIA case definitions: a feasibility assessment","volume":"36","author":"Stuurman","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.07.048_b0200","doi-asserted-by":"crossref","unstructured":"Hozbor D, Ulloa-Gutierrez R, Marino C, Wirsing von K\u00f6nig CH, Tan T, Forsyth K. Pertussis in Latin America: Recent epidemiological data presented at the 2017 Global Pertussis Initiative meeting. Vaccine 2019. pii: S0264-410X(19)30885-0.","DOI":"10.1016\/j.vaccine.2019.07.007"},{"key":"10.1016\/j.vaccine.2020.07.048_b0205","article-title":"Health outcomes of young children born to mothers who received 2009 pandemic H1N1 influenza vaccination during pregnancy: retrospective cohort study","volume":"366","author":"Walsh","year":"2019","journal-title":"BMJ"},{"key":"10.1016\/j.vaccine.2020.07.048_b0210","unstructured":"World Healh Organization. Low Birth Weight Policy Brief. Global Nutrition Targets 2025. WHO\/NMH\/NHD\/14.5. Available from: https:\/\/www.who.int\/nutrition\/publications\/globaltargets2025_policybrief_lbw\/en\/."},{"issue":"9890","key":"10.1016\/j.vaccine.2020.07.048_b0215","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S0140-6736(13)60993-9","article-title":"Mortality risk in preterm and small-for-gestational-age infants in low-income and middle-income countries: a pooled country analysis","volume":"382","author":"Katz","year":"2013","journal-title":"Lancet"},{"issue":"43","key":"10.1016\/j.vaccine.2020.07.048_b0220","doi-asserted-by":"crossref","first-page":"5738","DOI":"10.1016\/j.vaccine.2017.08.037","article-title":"WHO taskforce to evaluate influenza data to inform vaccine impact and economic modelling. Influenza epidemiology and immunization during pregnancy: Final report of a World Health Organization working group","volume":"35","author":"Fell","year":"2017","journal-title":"Vaccine"},{"issue":"Jan","key":"10.1016\/j.vaccine.2020.07.048_b0225","article-title":"Using the E-value to assess the potential effect of unmeasured confounding in observational studies","author":"Haneuse","year":"2019","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.vaccine.2020.07.048_b0230","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1186\/s12879-019-4318-3","article-title":"Pregnancy as a risk factor for severe influenza infection: an individual participant data meta-analysis","volume":"19","author":"Mertz","year":"2019","journal-title":"BMC Infect Dis"},{"issue":"48 Pt A","key":"10.1016\/j.vaccine.2020.07.048_b0235","doi-asserted-by":"crossref","first-page":"6575","DOI":"10.1016\/j.vaccine.2017.03.103","article-title":"Immunization in pregnancy clinical research in low- and middle-income countries - study design, regulatory and safety considerations","volume":"35","author":"Kochhar","year":"2017","journal-title":"Vaccine"},{"issue":"8","key":"10.1016\/j.vaccine.2020.07.048_b0240","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/S1473-3099(14)70804-7","article-title":"Estimates of possible severe bacterial infection in neonates in sub-Saharan Africa, south Asia, and Latin America for 2012: a systematic review and meta-analysis","volume":"14","author":"Seale","year":"2014","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2020.07.048_b0245","unstructured":"World Health Organization, 2006. Neonatal and perinatal mortality: country, regional and global estimates. World Health Organization, Geneva. Available from: http:\/\/www.who.int\/iris\/handle\/10665\/43444."},{"issue":"5","key":"10.1016\/j.vaccine.2020.07.048_b0250","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1097\/INF.0000000000001914","article-title":"Maternal influenza immunization and prevention of severe clinical pneumonia in young infants: analysis of randomized controlled trials conducted in Nepal, Mali and South Africa","volume":"37","author":"Omer","year":"2018","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2020.07.048_b0255","unstructured":"The electronic medicines compendium. Summary of Product Characteristics (SmPC) of quadrivalent Influenza vaccine (Split virion, inactivated). Available on line: https:\/\/www.medicines.org.uk\/emc\/product\/666\/smpc [Last accessed Sept 18, 2019]."},{"issue":"10228","key":"10.1016\/j.vaccine.2020.07.048_b0260","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/S0140-6736(19)33177-0","article-title":"Generating comparative evidence on new drugs and devices after approval","volume":"395","author":"Cipriani","year":"2020","journal-title":"Lancet"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X20309798?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X20309798?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:58:12Z","timestamp":1759402692000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X20309798"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":52,"alternative-id":["S0264410X20309798"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2020.07.048","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Adverse events associated with the use of recommended vaccines during pregnancy: An overview of systematic reviews","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2020.07.048","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}